The OXY-1 System removes carbon dioxide and adds oxygen to a patient's blood, eliminating the need for bulky oxygen tanks and allowing patients to move around more easily. Breethe's medical devices help improve outcomes for those suffering from acute and chronic lung problems, offering a new treatment option that enhances their quality of life. Founded in 2014 and headquartered in Baltimore, Maryland, Breethe's team of experts in cardiothoracic surgery, fluid mechanics, and product development engineering aim to address the limited treatment options for end-stage lung failure.